Onconetix, Inc. (ONCO)
0.7041
+0.03
(+4.42%)
USD |
NASDAQ |
Sep 03, 15:43
Onconetix Net Income (TTM) : -10.20M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.20M |
| March 31, 2026 | -9.701M |
| December 31, 2025 | -14.03M |
| September 30, 2025 | -49.14M |
| June 30, 2025 | -44.18M |
| March 31, 2025 | -56.12M |
| December 31, 2024 | -58.69M |
| September 30, 2024 | -51.60M |
| June 30, 2024 | -53.12M |
| March 31, 2024 | -45.68M |
| Date | Value |
|---|---|
| December 31, 2023 | -37.41M |
| September 30, 2023 | -18.28M |
| June 30, 2023 | -16.80M |
| March 31, 2023 | -14.20M |
| December 31, 2022 | -13.42M |
| September 30, 2022 | -11.41M |
| June 30, 2022 | -8.634M |
| March 31, 2022 | -4.696M |
| December 31, 2021 | -3.030M |
| September 30, 2021 | -2.160M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Aprea Therapeutics, Inc. | -12.31M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |